SCHEMBL264293

SCHEMBL264293

CC(C)(C)c1ccc2ncccc2c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.58
NPC1 O15118 4/20 0.57
POLB P06746 3/20 0.57
RAB9A P51151 3/20 0.57
MAPT P10636 3/20 0.53
HTT P42858 2/20 0.53
ATM Q13315 2/20 0.53
KDM4E B2RXH2 1/20 0.53
TP53 P04637 1/20 0.53
HSP90AA1 P07900 1/20 0.53
HSP90AB1 P08238 1/20 0.53
TSHR P16473 1/20 0.53
CASP1 P29466 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
HSD17B10 Q99714 1/20 0.53
METAP2 P50579 1/20 0.48
ALOX15 P16050 1/20 0.46
PLK1 P53350 1/20 0.46
DYRK1A Q13627 1/20 0.46
PDGFRB P09619 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1329308 0.85 ALDH1A1 (0.55) ALDH1A1NPC1POLBRAB9AMAPT
SCHEMBL28270720 0.85 ALDH1A1 (0.55) ALDH1A1NPC1POLBRAB9AMAPT
SCHEMBL20991097 0.85 ALDH1A1 (0.55) ALDH1A1NPC1POLBRAB9AMAPT
SCHEMBL28359467 0.85 ALDH1A1 (0.55) ALDH1A1NPC1POLBRAB9AMAPT
SCHEMBL1329887 0.85 ALDH1A1 (0.55) ALDH1A1NPC1POLBRAB9AMAPT
SCHEMBL28563865 0.85 ALDH1A1 (0.55) ALDH1A1NPC1POLBRAB9AMAPT
SCHEMBL420840 0.85 ALDH1A1 (0.58) ALDH1A1NPC1POLBRAB9AMAPT
Iodide SCHEMBL28543032 0.84 ALDH1A1 (0.53) ALDH1A1NPC1POLBRAB9AMAPT
SCHEMBL27100360 0.82 ALDH1A1 (0.51) ALDH1A1NPC1POLBRAB9AMAPT
SCHEMBL10285521 0.82 ALDH1A1 (0.51) ALDH1A1NPC1POLBRAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 763 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12529008-B2 Natural semi-solid perfume EXPRESSIONS PARFUMEES (FR) 2026-01-20 US disclosed
EP-4419065-B1 FRAGRANCING COMPLEX, FRAGRANCING COMPOSITION AND FRAGRANCED AQUEOUS COMPOSITION OF NATURAL ORIGIN EXPRESSIONS PARFUMEES (FR) 2025-12-03 EP disclosed
WO-2025215062-A1 LIQUID FRAGRANCE COMPLEX FOR LAUNDRY, FRAGRANCE COMPOSITION, AND ASSOCIATED MANUFACTURING METHOD EXPRESSIONS PARFUMEES (FR) 2025-10-16 WO disclosed
US-12290583-B2 Perfuming complex, perfuming composition and perfumed aqueous composition of natural origin EXPRESSIONS PARFUMÉES (FR) 2025-05-06 US disclosed
US-20250112240-A1 POLYIMIDE BINDER PRECURSOR COMPOSITION, AND POWER STORAGE DEVICE USING SAME UBE CORPORATION (JP) 2025-04-03 US disclosed
CN-118234470-B Perfuming complex of natural origin, perfuming composition and aqueous fragrance composition 伊碧申香料有限公司 2025-03-07 CN disclosed
EP-4489721-A1 READY-FOR-USE MILKY, VISCOUS AND STICKY PERFUME COMPLEX AND ASSOCIATED PERFUMED COMPOSITION Expressions Parfumees (FR) 2025-01-15 EP disclosed
US-12176543-B2 Polyimide-based binder for power storage device, electrode mixture paste, negative electrode active material layer, negative electrode sheet for power storage device, and power storage device UBE CORPORATION (JP) 2024-12-24 US disclosed
US-20240415745-A1 PERFUMING COMPLEX, PERFUMING COMPOSITION AND PERFUMED AQUEOUS COMPOSITION OF NATURAL ORIGIN EXPRESSIONS PARFUMÉES (FR) 2024-12-19 US disclosed
EP-3805294-B1 ELECTRODE BINDER RESIN COMPOSITION, ELECTRODE MIXTURE PASTE, AND ELECTRODE UBE CORP (JP) 2024-12-18 EP disclosed
US-7226950-B2 Sodium channel modulators THERAVANCE, INC. (US) 2007-06-05 US disclosed
US-20070123576-A1 Compounds inducing differentiation of myoblasts or muscle fibers into neuron cells, pharmaceutical composition including said compounds, a method for inducing neuron differentiation and a screening method for identifying additional compounds useful for inducing neuron differentiation INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (KR) 2007-05-31 US disclosed
US-20070105852-A1 Thiophene and furan compounds ELI LILLY AND COMPANY 2007-05-10 US disclosed
US-20070099825-A1 ethyl 2-(biphenyl-4-yl)-6-(tert-butoxycarbonylamino)-2-methoxy-8-(2-nitrophenylsulfonyl)-5,16-dioxo-1,2,3,5,6,7,10,11,13a,14,14a,15,16,16a-hexadecahydrocyclopropa[n]pyrrolo[2,1-c][1,4,8]triazacyclopentadecine-14a-carboxylate; viricide; synergistic with other active ingredients BRISTOL-MYERS SQUIBB COMPANY 2007-05-03 US disclosed
US-20070099825-A1 ethyl 2-(biphenyl-4-yl)-6-(tert-butoxycarbonylamino)-2-methoxy-8-(2-nitrophenylsulfonyl)-5,16-dioxo-1,2,3,5,6,7,10,11,13a,14,14a,15,16,16a-hexadecahydrocyclopropa[n]pyrrolo[2,1-c][1,4,8]triazacyclopentadecine-14a-carboxylate; viricide; synergistic with other active ingredients BRISTOL-MYERS SQUIBB COMPANY 2007-05-03 US disclosed
US-20070072898-A1 Pyrazolo[1,5-a]pyridine derivatives or pharmaceutically acceptable salts thereof TEIJIN PHARMA LIMITED 2007-03-29 US disclosed
US-20070043033-A1 Unsolvated benzodiazepine compositions and methods THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2007-02-22 US disclosed
US-20070037855-A1 Compounds for inhibiting beta-amyloid production and methods of identifying the compounds ALZHEIMER'S INSTITUTE OF AMERICA, INC. 2007-02-15 US disclosed
US-20070027321-A1 Bipyridyl amines and ethers as modulators of metabotropic glutamate receptor-5 MERCK SHARP & DOHME CORP. 2007-02-01 US disclosed
US-4207320-A FUNGICIDES WARNER-LAMBERT COMPANY (US) 1980-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070072898-A1 Pyrazolo[1,5-a]pyridine derivatives or pharmaceutically acceptable salts thereof MAPKAPK2, MAP4K2, MAPKAPK5 ALDH1A1 3152/4885NPC1 4516/4885POLB 3893/4885
US-20070099825-A1 ethyl 2-(biphenyl-4-yl)-6-(tert-butoxycarbonylamino)-2-methoxy-8-(2-nitrophenylsulfonyl)-5,16-dioxo-1,2,3,5,6,7,10,11,13a,14,14a,15,16,16a-hexadecahydrocyclopropa[n]pyrrolo[2,1-c][1,4,8]triazacyclopentadecine-14a-carboxylate; viricide; synergistic with other active ingredients TERT, VIP, YWHAZ ALDH1A1 3464/4885NPC1 2958/4885POLB 391/4885
US-20070037855-A1 Compounds for inhibiting beta-amyloid production and methods of identifying the compounds APP, PSEN1, PSEN2 ALDH1A1 3939/4885NPC1 846/4885POLB 4123/4885
US-20070123576-A1 Compounds inducing differentiation of myoblasts or muscle fibers into neuron cells, pharmaceutical composition including said compounds, a method for inducing neuron differentiation and a screening method for identifying additional compounds useful for inducing neuron differentiation TNNC1, TNNI3, PYGM ALDH1A1 313/4885NPC1 3112/4885POLB 4293/4885
US-12290583-B2 Perfuming complex, perfuming composition and perfumed aqueous composition of natural origin DAGLA, DAGLB, CAPRIN1 ALDH1A1 2770/4885NPC1 3917/4885POLB 707/4885
US-20070027321-A1 Bipyridyl amines and ethers as modulators of metabotropic glutamate receptor-5 GRM5, GRIK5, GRM1 ALDH1A1 2178/4885NPC1 3553/4885POLB 3392/4885
US-20240415745-A1 PERFUMING COMPLEX, PERFUMING COMPOSITION AND PERFUMED AQUEOUS COMPOSITION OF NATURAL ORIGIN DAGLA, DAGLB, CAPRIN1 ALDH1A1 2770/4885NPC1 3917/4885POLB 707/4885
US-20070043033-A1 Unsolvated benzodiazepine compositions and methods GABRA5, GABRA3, GABRA6 ALDH1A1 2225/4885NPC1 302/4885POLB 3400/4885
US-20070105852-A1 Thiophene and furan compounds PSEN2, PSEN1, TPMT ALDH1A1 1344/4885NPC1 1271/4885POLB 4469/4885
US-12529008-B2 Natural semi-solid perfume TES, TAS2R50, TAS2R10 ALDH1A1 1674/4885NPC1 4454/4885POLB 2726/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.